Jacob M. Chacko
2021
In 2021, Jacob M. Chacko earned a total compensation of $7M as President and Chief Executive Officer at Oric Pharmaceuticals, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $335,200 |
|---|---|
| Option Awards | $6,092,240 |
| Salary | $536,278 |
| Other | $12,206 |
| Total | $6,975,924 |
Chacko received $6.1M in option awards, accounting for 87% of the total pay in 2021.
Chacko also received $335.2K in non-equity incentive plan, $536.3K in salary and $12.2K in other compensation.
Rankings
In 2021, Jacob M. Chacko's compensation ranked 1,754th out of 12,415 executives tracked by ExecPay. In other words, Chacko earned more than 85.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,754 out of 12,415 | 86th |
Division Manufacturing | 647 out of 5,508 | 88th |
Major group Chemicals And Allied Products | 239 out of 2,378 | 90th |
Industry group Drugs | 201 out of 2,099 | 90th |
Industry Pharmaceutical Preparations | 136 out of 1,549 | 91st |
Source: SEC filing on April 27, 2022.
Chacko's colleagues
We found two more compensation records of executives who worked with Jacob M. Chacko at Oric Pharmaceuticals in 2021.
News
Oric Pharmaceuticals CEO Jacob Chacko's 2023 pay falls 28% to $3.2M
April 24, 2024
Oric Pharmaceuticals CEO Jacob Chacko's 2022 pay falls 37% to $4.4M
April 26, 2023
Oric Pharmaceuticals CEO Jacob Chacko's 2021 pay rises 19% to $7M
April 27, 2022
Oric Pharmaceuticals CEO Jacob Chacko's 2020 pay jumps 774% to $5.9M
April 26, 2021